Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator agent that acts directly on vascular smooth muscle. Its mechanism of action is not fully elucidated but may involve beta-adrenergic stimulation or phosphodiesterase inhibition leading to increased intracellular cyclic AMP.
## Primary Indications
* Management of peripheral vascular disease, including intermittent claudication and Raynaud's disease, to improve blood flow.
* Historically used for threatened premature labor, but efficacy is not well-established and not a current guideline-recommended use.
## Adult Dosing
* **Oral:** The typical dose is 10 mg to 20 mg taken by mouth three to four times daily.
* **Maximum Dose:** Not explicitly defined, but doses exceeding 20 mg per administration are generally not recommended.
## Pediatric Dosing
There is no established or recommended pediatric dosing for isoxsuprine hydrochloride due to lack of clinical trials and safety data.
## Dose Adjustments
No specific dose adjustments are routinely recommended for renal or hepatic impairment. However, caution is advised due to potential for reduced drug clearance.
## Contraindications
* Known hypersensitivity to isoxsuprine hydrochloride.
* Severe hypotension.
* Tachycardia.
* Glaucoma.
* Recent myocardial infarction.
## Adverse Effects
Common adverse effects include:
* Nausea and vomiting
* Dizziness and lightheadedness
* Weakness
* Abdominal distress
* Hypotension
* Tachycardia
* Rash
Less common but serious effects may include:
* Gastrointestinal bleeding
* Bromism (with prolonged high doses of bromides if used concurrently, although this is rare with isoxsuprine alone).
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications.
* **Vasopressors:** Concurrent use may lead to excessive blood pressure lowering.
## Monitoring
* Blood pressure and heart rate should be monitored regularly, especially at the start of therapy or with dose changes, due to the risk of hypotension and tachycardia.
* Monitor for signs and symptoms of peripheral vascular disease improvement (e.g., increased walking distance, decreased pain).
## Clinical Pearls
* The efficacy of isoxsuprine in improving peripheral circulation is often debated and clinical benefit may be modest.
* Avoid use in patients with conditions that could be exacerbated by vasodilation or increased heart rate.
* Patient education should include potential side effects and the importance of regular monitoring.
***
*Disclaimer: This information is for educational purposes only and does not substitute professional medical advice. Always consult with a qualified healthcare provider and refer to the most current prescribing information and institutional protocols for definitive guidance.*
